Joren Stroobants
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
The development of biologically contained Sudan virus as an alternative and safe tool for fundamental filovirus research.
Journal: Emerging microbes & infections
Published: June 17, 2026
New determinant of influenza hemagglutinin cleavability identified through random mutagenesis for acid-stabilizing mutations.
Journal: Microbiology spectrum
Published: June 15, 2026
Sec61 translocon inhibitor flavitransin blocks selectively dengue virus polyprotein insertion in the ER with pan-orthoflavivirus antiviral potency.
Journal: Cell reports
Published: May 15, 2025
Generation of Biologically Contained Marburg Virus.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 25, 2024
Cellular electrical impedance to profile SARS-CoV-2 fusion inhibitors and to assess the fusogenic potential of spike mutants.
Journal: Antiviral research
Published: January 31, 2023
Carbohydrate-binding protein from stinging nettle as fusion inhibitor for SARS-CoV-2 variants of concern.
Journal: Frontiers in cellular and infection microbiology
Published: July 08, 2022
SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening.
Journal: Antiviral research
Published: February 13, 2022
Identification of novel Ebola virus inhibitors using biologically contained virus.
Journal: Antiviral research
Published: December 14, 2021
A Proteomic Study on the Membrane Protein Fraction of T Cells Confirms High Substrate Selectivity for the ER Translocation Inhibitor Cyclotriazadisulfonamide.
Journal: Molecular & cellular proteomics : MCP
Published: April 16, 2021
Last Updated: 09/26/2026